Axovant Announces Formation of Arvelle Therapeutics and Strategic Transition of Legacy Small Molecule Team Into Newly Formed Company
Transition of small molecule expertise to Arvelle completes transformation of Axovant into a company focused exclusively on gene therapies Axovant […]